In addition to the expression on endothelial cells/lymphatic endothelial cells, VEGFR-2/VEGFR-3 has been shown to be expressed in a variety of human malignancies, including breast carcinoma [7, 8]. This evidence concerns the gene FLT4 and breast carcinoma.